SWARANJIT GILL: Open Payments
NPI 1669536421 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 32 payments from 6 companies in 2025. Trend: 2023 $831 · 2024 $1,227 · 2025 $1,574
Food & beverage: $1,574
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $631 |
| E.R. Squibb & Sons, L.L.C. | 6 | $341 |
| Janssen Pharmaceuticals, Inc | 4 | $246 |
| Otsuka America Pharmaceutical, Inc. | 4 | $165 |
| Alkermes, Inc. | 2 | $141 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
Products named: FANAPT, COBENFY, INVEGA SUSTENNA, REXULTI, LYBALVI, ABILIFY MAINTENA, UZEDY, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
